Oakwood Labs

Since our founding in 1997, Oakwood Laboratories has been driven by a single purpose — to advance global healthcare through the development of innovative sustained-release injectable therapies. Leveraging our proprietary Chroniject™ technology platform, we design and manufacture pharmaceutical products that deliver enhanced therapeutic benefits, improving both treatment effectiveness and patient quality of life across a broad range of disease states and therapeutic areas.